Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. More Details
+ 1 more risk
Average dividend payer with mediocre balance sheet.
Share Price & News
How has Medtronic's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MDT is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: MDT's weekly volatility (3%) has been stable over the past year.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: MDT underperformed the US Medical Equipment industry which returned 35.8% over the past year.
Return vs Market: MDT underperformed the US Market which returned 36.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Medtronic's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StShould We Be Excited About The Trends Of Returns At Medtronic (NYSE:MDT)?
3 weeks ago | Simply Wall StIs Medtronic plc (NYSE:MDT) Worth US$118 Based On Its Intrinsic Value?
1 month ago | Simply Wall StWhat Kind Of Shareholders Own Medtronic plc (NYSE:MDT)?
Is Medtronic undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MDT ($117.86) is trading above our estimate of fair value ($85.29)
Significantly Below Fair Value: MDT is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MDT is good value based on its PE Ratio (51.7x) compared to the US Medical Equipment industry average (55.1x).
PE vs Market: MDT is poor value based on its PE Ratio (51.7x) compared to the US market (21.2x).
Price to Earnings Growth Ratio
PEG Ratio: MDT is poor value based on its PEG Ratio (2.6x)
Price to Book Ratio
PB vs Industry: MDT is good value based on its PB Ratio (3.1x) compared to the US Medical Equipment industry average (5.2x).
How is Medtronic forecast to perform in the next 1 to 3 years based on estimates from 25 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDT's forecast earnings growth (19.6% per year) is above the savings rate (2%).
Earnings vs Market: MDT's earnings (19.6% per year) are forecast to grow slower than the US market (20% per year).
High Growth Earnings: MDT's earnings are forecast to grow, but not significantly.
Revenue vs Market: MDT's revenue (6.1% per year) is forecast to grow slower than the US market (10.4% per year).
High Growth Revenue: MDT's revenue (6.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MDT's Return on Equity is forecast to be low in 3 years time (16.2%).
How has Medtronic performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MDT has a large one-off loss of $1.3B impacting its January 29 2021 financial results.
Growing Profit Margin: MDT's current net profit margins (11%) are lower than last year (17.4%).
Past Earnings Growth Analysis
Earnings Trend: MDT's earnings have grown by 4.5% per year over the past 5 years.
Accelerating Growth: MDT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MDT had negative earnings growth (-43.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (9.8%).
Return on Equity
High ROE: MDT's Return on Equity (6%) is considered low.
How is Medtronic's financial position?
Financial Position Analysis
Short Term Liabilities: MDT's short term assets ($26.3B) exceed its short term liabilities ($12.5B).
Long Term Liabilities: MDT's short term assets ($26.3B) do not cover its long term liabilities ($33.8B).
Debt to Equity History and Analysis
Debt Level: MDT's debt to equity ratio (59.1%) is considered high.
Reducing Debt: MDT's debt to equity ratio has reduced from 70.1% to 59.1% over the past 5 years.
Debt Coverage: MDT's debt is not well covered by operating cash flow (19.8%).
Interest Coverage: MDT's interest payments on its debt are well covered by EBIT (17x coverage).
What is Medtronic current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: MDT's dividend (1.97%) is higher than the bottom 25% of dividend payers in the US market (1.33%).
High Dividend: MDT's dividend (1.97%) is low compared to the top 25% of dividend payers in the US market (3.76%).
Stability and Growth of Payments
Stable Dividend: MDT's dividends per share have been stable in the past 10 years.
Growing Dividend: MDT's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (100%), MDT's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: MDT's dividends in 3 years are forecast to be well covered by earnings (36.4% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Geoff Martha (50 yo)
Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020 and Chairman since December 11 20...
CEO Compensation Analysis
Compensation vs Market: Geoff's total compensation ($USD6.31M) is below average for companies of similar size in the US market ($USD10.54M).
Compensation vs Earnings: Insufficient data to compare Geoff's compensation with company performance.
|CEO & Chairman of the Board||0.83yr||US$6.31m||0.0018% |
|Executive VP & CFO||4.67yrs||US$4.77m||0.0066% |
|Senior VP||6.08yrs||US$3.90m||0.0038% |
|Senior Vice President of Global Operations and Business Services||4.33yrs||no data||no data|
|Senior VP & Chief Medical and Scientific Officer||6.08yrs||no data||0.0055% |
|Chief Information Officer||no data||no data||no data|
|Vice President of Investor Relations||5.67yrs||no data||no data|
|Public Relations & Interim Chief Communications Officer||no data||no data||no data|
|Senior VP & Chief Human Resources Officer||6.08yrs||US$5.52m||0.0011% |
|EVP, President of Diabetes Operating Unit & EVP & President of Cardiovascular Portfolio||no data||no data||0.0011% |
|Executive VP and Group President||6.08yrs||US$6.50m||0.0032% |
|Executive VP & President of Americas Region||2.42yrs||no data||0.0031% |
Experienced Management: MDT's management team is seasoned and experienced (5.7 years average tenure).
|CEO & Chairman of the Board||0.83yr||US$6.31m||0.0018% |
|Lead Independent Director||3.58yrs||US$410.05k||0.00064% |
|Independent Director||14.08yrs||US$365.05k||0.0024% |
|Independent Director||14.08yrs||US$350.05k||0.0010% |
|Independent Director||6.08yrs||US$375.05k||0.0027% |
|Independent Director||19.08yrs||US$365.05k||0.0081% |
|Independent Director||6.08yrs||US$370.05k||0.0022% |
|Independent Director||21.08yrs||US$370.05k||0.0044% |
|Independent Director||1.92yrs||US$350.05k||0.000020% |
|Independent Director||7.08yrs||US$385.05k||0.00057% |
|Independent Director||10.08yrs||US$370.05k||0.00079% |
|Independent Director||0.42yr||no data||no data|
Experienced Board: MDT's board of directors are considered experienced (6.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: MDT insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Medtronic plc's company bio, employee growth, exchange listings and data sources
- Name: Medtronic plc
- Ticker: MDT
- Exchange: NYSE
- Founded: 1949
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$158.813b
- Shares outstanding: 1.35b
- Website: https://www.medtronic.com
Number of Employees
- Medtronic plc
- 20 On Hatch
- Lower Hatch Street
- Co. Dublin
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|2M6||XTRA (XETRA Trading Platform)||Yes||New Ordinary Shares||DE||EUR||Jan 1969|
|MDT N||BMV (Bolsa Mexicana de Valores)||Yes||New Ordinary Shares||MX||MXN||Jan 1969|
|2M6||DB (Deutsche Boerse AG)||Yes||New Ordinary Shares||DE||EUR||Jan 1969|
|MDT||NYSE (New York Stock Exchange)||Yes||New Ordinary Shares||US||USD||Jan 1969|
|MDT||SWX (SIX Swiss Exchange)||Yes||New Ordinary Shares||CH||CHF||Jan 1969|
|0Y6X||LSE (London Stock Exchange)||Yes||New Ordinary Shares||GB||USD||Jan 1969|
|2M6||ETLX (Eurotlx)||Yes||New Ordinary Shares||IT||EUR||Jan 1969|
|MDT||BASE (Buenos Aires Stock Exchange)||CEDEAR EACH 4 REP 1||AR||ARS||Jul 2001|
|MDTC34||BOVESPA (Bolsa de Valores de Sao Paulo)||BDR EACH 2 REP 1 COM||BR||BRL||Apr 2016|
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vasc...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/03/01 23:32|
|End of Day Share Price||2021/03/01 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.